| |
| |
|
| Insider
Information: |
Forbes William P |
| Relationship: |
|
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
92,729 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$229,561 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,729 |
|
|
| Total
Value |
$229,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 195.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
President, Medical, R&... |
2015-04-01 |
0 |
2006-07-13 |
0 |
Premium* |
|
|
Beyond Air Ord Shs |
XAIR |
Director |
2023-03-17 |
9,855 |
2023-03-17 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
|
2024-04-19 |
82,874 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2023-03-17 |
4 |
B |
$6.46 |
$32,300 |
D/D |
5,000 |
9,855 |
2.39 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Chief Development Officer |
• – – |
2023-06-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Chief Development Officer |
• – – |
2023-11-16 |
4 |
B |
$0.94 |
$46,995 |
D/D |
50,000 |
54,000 |
2.74 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Chief Development Officer |
• – – |
2023-11-17 |
4 |
B |
$1.09 |
$27,250 |
D/D |
25,000 |
79,000 |
2.74 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Chief Development Officer |
• – – |
2024-04-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,874 |
82,874 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2006-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
13,500 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2007-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,845 |
27,345 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2007-07-03 |
4 |
AS |
$12.31 |
$13,721 |
D/D |
(1,113) |
26,232 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
51,013 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2008-07-01 |
4 |
D |
$7.03 |
$15,600 |
D/D |
(2,219) |
24,013 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,890 |
67,762 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2009-07-01 |
4 |
D |
$9.87 |
$50,742 |
D/D |
(5,141) |
45,872 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2009-12-23 |
4 |
AS |
$25.00 |
$125,000 |
D/D |
(5,000) |
62,762 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-04-01 |
4 |
AS |
$38.00 |
$71,402 |
D/D |
(1,879) |
60,883 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-04-14 |
4 |
AS |
$40.03 |
$400,251 |
D/D |
(10,000) |
60,883 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-04-14 |
4 |
OE |
$17.53 |
$175,300 |
D/D |
10,000 |
70,883 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-07-01 |
4 |
D |
$39.03 |
$296,082 |
D/D |
(7,586) |
53,297 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,055 |
68,352 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-09-15 |
4 |
AS |
$40.50 |
$433,108 |
D/D |
(10,695) |
57,657 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-11-10 |
4 |
AS |
$40.01 |
$400,053 |
D/D |
(10,000) |
57,657 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2010-11-10 |
4 |
OE |
$17.53 |
$175,300 |
D/D |
10,000 |
67,657 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
V.P. Research& Devel & CDO |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,698 |
80,355 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Research&Devel & CDO |
• – – |
2011-05-16 |
4 |
S |
$40.35 |
$806,986 |
D/D |
(20,000) |
80,355 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Research&Devel & CDO |
• – – |
2011-05-16 |
4 |
OE |
$17.53 |
$350,600 |
D/D |
20,000 |
100,355 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Research&Devel & CDO |
• – – |
2011-07-01 |
4 |
D |
$39.83 |
$366,914 |
D/D |
(9,212) |
71,143 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
